Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Health services and systems news

Show

From To
Cryptococcal meningitis: a blind spot in curbing AIDS

Cryptococcal meningitis, a co-infection of HIV, is a leading killer of patients with AIDS worldwide. Yet it receives little global attention.

Published
15 April 2016
From
The Lancet (requires free registration)
Gilead Statement on the Approval of PrEP in Peru

Gilead Sciences, Inc. is pleased to share that the Peru Ministry of Health has approved the use of once- daily oral Truvada® (emtricitabine 200mg/tenofovir disoproxil fumarate 300mg) as pre-exposure prophylaxis (PrEP), in combination with safer sex practices, to help reduce the risk of sexually acquired HIV-1 infection among uninfected adults at high risk .

Published
14 April 2016
From
Gilead Sciences
Innovative new programme set to treat 10,000 patients co-infected with hepatitis C and HIV in Africa and Asia

The World Hepatitis Alliance welcomes the announcement of a new programme initiated by the Clinton Health Access Initiative, Inc. (CHAI) and AmeriCares that aims to treat 10,000 co-infected HIV and hepatitis C patients in Africa and Asia with new hepatitis C treatment Daklinza (daclatasvir).

Published
14 April 2016
From
World Hepatitis Alliance
Hepatitis C: The task now is identifying people who don’t know they’re infected and connecting them to care

Interview with Luis Mendão, chair of both the European AIDS Treatment Group (EATG) and Group of Activists on Treatments (GAT), a treatment activist group in Portugal.

Published
14 April 2016
From
BioMed Central blogs
Hepatitis C: Let’s not forget ‘prevention as prevention’

Interview with Eberhard Schatz, one of the two coordinators of Correlation, the European social inclusion and health network.

Published
14 April 2016
From
BioMed Central blogs
$300 hepatitis C combination to enter clinical trials

The Drugs for Neglected Diseases Initiative (DNDI) is launching clinical trials in Thailand and Malaysia to test a combination of sofosbuvir and ravidasvir, an NS5A inhibitor, in

Published
13 April 2016
By
Keith Alcorn
Plan for Poorer Countries to Fund HIV Response Raises Concerns

Calls for low and middle income countries to contribute an additional 6.1 billion dollars to the global HIV response by 2020 could see some vulnerable groups left behind, said HIV activists meeting at the United Nations last week.

Published
12 April 2016
From
Inter Press Service
Primary care doctors and nurse practitioners can successfully treat people with hepatitis C

Direct-acting antiviral therapy for hepatitis C delivered by non-specialists such as primary care physicians and nurse practitioners is safe and effective – even for the most difficult-to-treat patients

Published
12 April 2016
By
Liz Highleyman
UK PrEP decision re-ignites HIV activism

The NHS should reopen the public consultation, emboldened by the renewed and much needed HIV activism.

Published
08 April 2016
From
The Lancet (editorial)
Kiev commits to ending the AIDS epidemic by 2030

Ahead of a Fast-Track cities event to take place in June at the 2016 United Nations General Assembly High-Level Meeting on Ending AIDS, the Mayor of Kiev, Vitali Klitschko, has committed the city to the UNAIDS Fast-Track approach to end the AIDS epidemic.

Published
07 April 2016
From
UNAIDS

Filter by country